pilocarpine has been researched along with pindolol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Koller, MM; Rajakumar, G; Scarpace, PJ | 1 |
| Böhm, E; Fabel, H | 1 |
| Fleming, WW; Torphy, TJ; Westfall, DP | 1 |
1 review(s) available for pilocarpine and pindolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for pilocarpine and pindolol
| Article | Year |
|---|---|
[Changes in lung function following administration of eyedrops containing timolol, metipranolol, pindolol and pilocarpine in healthy probands and patients with mild bronchial asthma].
Topics: Airway Resistance; Asthma; Bronchial Spasm; Clinical Trials as Topic; Double-Blind Method; Humans; Lung Volume Measurements; Metipranolol; Ophthalmic Solutions; Pilocarpine; Pindolol; Propanolamines; Random Allocation; Timolol | 1987 |
6 other study(ies) available for pilocarpine and pindolol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Beta-adrenergic receptors and salivary gland secretion during aging.
Topics: Aging; Animals; Dose-Response Relationship, Drug; Female; Iodocyanopindolol; Isoproterenol; Pilocarpine; Pindolol; Rats; Rats, Inbred F344; Receptors, Adrenergic, beta; Salivary Glands; Salivary Proteins and Peptides | 1992 |
Effect of reserpine pretreatment on mechanical responsiveness and [125I]Iodohydroxybenzylpindolol binding sites in the guinea-pig right atrium.
Topics: Aminophylline; Animals; Binding Sites; Calcium; Guinea Pigs; Heart; Heart Atria; Heart Rate; Histamine; Isoproterenol; Kinetics; Male; Myocardial Contraction; Myocardium; Pilocarpine; Pindolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Reserpine | 1982 |